NLRP3 inflammasome seems to act as a negative modulator of tumorigenesis in colitis-associated cancer (59), which is confirmatory to the study emphasizing the role of NLRP3 inflammasome in the regulation of intestinal homeostasis and thus protection against colitis (60). This evidence concerns the gene NLRP3 and cancer.